Pharmacy
News
FDA approves glasdegib for AML
The U.S.
News
FDA approves first treatment for primary HLH
The U.S.
News
Eltrombopag approved as first-line SAA therapy
The U.S.
News
Quick FDA approval for brentuximab vedotin in PTCL
The U.S.
News
FDA approves generic drugs for APL
The U.S.
News
FDA approves elotuzumab combo for rel/ref MM
The U.S.
News
FDA and EC approve pegfilgrastim biosimilar
The U.S.
News
Health Canada approves pralatrexate for rel/ref PTCL
Health Canada has granted conditional approval for pralatrexate (Folotyn®) to treat relapsed or refractory peripheral T-cell lymphoma (PTCL)....
News
EC approves venetoclax in combo with rituximab
The European Commission (EC) has approved a new indication for venetoclax (Venclyxto®). The drug is now approved for use in combination with...
News
Canada approves Jivi for hemophilia A
Health Canada has approved Jivi® (antihemophilic factor [recombinant, B-domain deleted, PEGylated]) for use in patients with hemophilia A. Jivi (...
News
Weighing the costs of CAR T-cell therapy
The cost-effectiveness of tisagenlecleucel (Kymriah) depends on long-term clinical outcomes, which are presently unknown, according to...